𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A randomized controlled clinical trial of recombinant human alpha-2a interferon (IFN) in cryptogenic chronic active liver disease: Preliminary results

✍ Scribed by Diodati, C.; Bonetti, P.; Maladorno, D.; Alberti, A.; Realdi, G.; Ruol, A.


Book ID
122569874
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
52 KB
Volume
9
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treatment of chronic hepatitis C with re
✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels